A Survey on Quetiapine Extended-release Tablets in Patients With Depression in Bipolar Disorder
Clinical trial NCT03403790 · COMPLETED
Trial details
- NCT number
- NCT03403790
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2018-01-15
- Primary completion
- 2020-03-19
- Enrollment
- 369
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.